Is Twist undervalued or overvalued?

As of 2025-03-17, the Intrinsic Value of Twist Bioscience Corp (TWST) is (155.84) USD. This Twist valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 39.96 USD, the upside of Twist Bioscience Corp is -490.00%. This means that Twist is overvalued by 490.00%.

The range of the Intrinsic Value is (318.66) - (104.37) USD

Note: result may not be accurate due to the invalid valuation result of DCF model.

	Range	Selected	Upside
a
DCF (Growth 5y)	(318.66) - (104.37)	(155.84)	-490.0%
DCF (Growth 10y)	(148.43) - (441.37)	(219.24)	-648.7%
DCF (EBITDA 5y)	(71.39) - (93.55)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(109.87) - (151.43)	(1,234.50)	-123450.0%
Fair Value	-16.54 - -16.54	-16.54	-141.39%
P/E	(54.91) - (77.80)	(58.55)	-246.5%
EV/EBITDA	(31.24) - (31.33)	(29.73)	-174.4%
EPV	(33.38) - (48.27)	(40.83)	-202.2%
DDM - Stable	(18.66) - (65.37)	(42.01)	-205.1%
DDM - Multi	(33.14) - (97.82)	(50.40)	-226.1%